SOX9 and neoplasm: The hormone-dependent inhibition of Sox9 is in agreement with our previous reports on the effects of estrogen contributing to a more differentiated phenotype by reducing the stem cell pool in the human breast [22, 23] and the association between high CSC content and poorly differentiated tumours [48, 49].